
Predictive Oncology POAI
Quarterly report 2026-Q1
added 05-15-2026
Predictive Oncology Total Inventories 2011-2026 | POAI
Annual Total Inventories Predictive Oncology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 45.8 K | 60.7 K | 430 K | 388 K | 290 K | 190 K | 241 K | 265 K | 272 K | 232 K | 367 K | 122 K | 145 K | 97.6 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 430 K | 45.8 K | 225 K |
Quarterly Total Inventories Predictive Oncology
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 38 K | 42.7 K | 45.8 K | 45.8 K | 504 K | 568 K | 442 K | 481 K | 440 K | 394 K | 380 K | 430 K | 494 K | 475 K | 456 K | 388 K | 398 K | 318 K | 293 K | 290 K | 290 K | 290 K | 290 K | 190 K | 190 K | 190 K | 190 K | 241 K | 241 K | 241 K | 241 K | 265 K | 265 K | 265 K | 265 K | 272 K | 272 K | 272 K | 272 K | 232 K | 232 K | 232 K | 232 K | 367 K | 367 K | 367 K | 367 K | 122 K | 122 K | 122 K | 122 K | 145 K | 145 K | 145 K | 145 K | 97.6 K | 97.6 K | 97.6 K | 97.6 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 568 K | 38 K | 263 K |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
846 M | $ 61.75 | 0.49 % | $ 12.3 B | ||
|
ICU Medical
ICUI
|
616 M | $ 129.31 | 4.57 % | $ 3.19 B | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 449.03 | 1.69 % | $ 160 B | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 117.0 | 2.78 % | $ 3.74 B | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 4.0 | 1.01 % | $ 185 M | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | $ 101.43 | 0.1 % | $ 2.3 B | ||
|
Masimo Corporation
MASI
|
459 M | $ 178.79 | -0.01 % | $ 9.53 B | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.4 | 14.99 % | $ 32.8 M | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | - | - | $ 28.6 M | ||
|
electroCore
ECOR
|
1.63 M | $ 6.13 | 3.81 % | $ 52 K | ||
|
Envista Holdings Corporation
NVST
|
288 M | $ 23.77 | 3.15 % | $ 3.99 B | ||
|
Haemonetics Corporation
HAE
|
365 M | $ 59.56 | 4.79 % | $ 3 B | ||
|
STERIS plc
STE
|
581 M | $ 215.97 | 0.67 % | $ 21.3 B | ||
|
Isoray
ISR
|
1.41 M | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
42 M | $ 143.82 | 2.71 % | $ 6.97 B | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 33.05 | 1.38 % | $ 1.64 B | ||
|
InfuSystem Holdings
INFU
|
5.39 M | $ 10.16 | 5.07 % | $ 210 M | ||
|
Microbot Medical
MBOT
|
584 K | $ 1.74 | 0.58 % | $ 79.7 M | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 135.18 | 1.81 % | $ 6.03 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 64.17 | 0.27 % | $ 208 M | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 64.49 | 1.13 % | $ 3.82 B | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 305.5 | 0.55 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 9.84 | 1.03 % | $ 1.96 B | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 26.09 | 4.57 % | $ 1.76 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.66 | -2.35 % | $ 19.8 M | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 63.47 | 4.43 % | $ 209 M | ||
|
BioLife Solutions
BLFS
|
30.2 M | $ 24.0 | 4.12 % | $ 1.15 B | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.85 | 7.56 % | $ 168 M | ||
|
Baxter International
BAX
|
2.23 B | $ 18.77 | 2.37 % | $ 9.63 B | ||
|
ResMed
RMD
|
744 M | $ 209.86 | 0.98 % | $ 30.7 B | ||
|
AtriCure
ATRC
|
78.5 M | $ 29.0 | 0.69 % | $ 1.38 B | ||
|
Harvard Bioscience
HBIO
|
20.8 M | $ 5.4 | 7.78 % | $ 240 M | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
62 M | $ 11.81 | 3.23 % | $ 482 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 146.95 | 0.02 % | $ 42.3 B | ||
|
Nephros
NEPH
|
3.23 M | $ 3.57 | -1.79 % | $ 37.9 M | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 3.07 | -0.32 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
170 M | $ 111.74 | 2.97 % | $ 6.28 M |